SURGLASSES raising USD 6.5M in Pre-A funding for AR expansion

SURGLASSES recently raising the successful completion of a $6.5 million Pre-A funding round. This investment was led by Taiwania Capital and saw participation from prominent venture capital firms including Integrated Capital, 500 STARTUPS V, L.P. from the United States, Wisdom Capital Limited Partnership,and Sustainable Impact Capital(SIC), marking a significant milestone in SURGLASSES’s growth journey in the medical technology sector. Additionally, it’s noteworthy to mention that the initial fundraising target for this round was $5 million, but it was oversubscribed and reached $6.5 million, which demonstrates investors’ highly-confidence on SURGLASSES.

The funds raised will primarily be directed towards accelerating the research, development, and promotion of SURGLASSES’s innovative product – the Caduceus S AR navigation system. Caduceus S is an FDA510(k) Clearance AR medical technology specially designed for complex spinal surgeries. The system allows real-time overlay of 3D spinal anatomy onto the patient during surgical procedures through multiple trackers and a transparent Head-Mounted Display (HMD), providing precise guidance and facilitating surgical operations for surgeons.

In essence, the Caduceus S system projects pre-planned trajectories onto the HMD, offering crucial guidance to surgeons without the need to shift focus to external monitors. This cutting-edge technology ensures a 100% field of view for the surgeon, enabling them to concentrate fully on surgical procedures, ultimately enhancing surgical precision. The seamless integration of the Caduceus S system not only improves surgical accuracy but also enhances ergonomics and efficiency within the operating room.

SURGLASSES believes that the Caduceus S system not only embodies state-of-the-art technology but is also infused with user-centric design, offering greater possibilities for complex spinal surgeries. In the future, SURGLASSES will continue to invest in research and development, contributing further to the advancement of medical technology, ultimately elevating surgical efficiency and accuracy.

Miron Wang, the CEO of SURGLASSES remarked, “Our AR spinal surgery navigation system is currently the most advanced AR system globally. Additionally, we have obtained a patent enabling precise navigation with just one C-arm. Compared to traditional navigation methods, our system exposes patients to less radiation during surgery, ensuring enhanced safety. We are poised to expedite market expansion in the United States.”

SURGLASSES extends a warm welcome to professionals from the medtech related field, both domestically and internationally, to join the company and collectively contribute to the research and development of medical technology, propelling the state-of-the-art AR augmented reality surgical navigation system, Caduceus S, to become a benchmark in the global medical community.
MB Bureau